US Breast Cancer Therapeutics Market is Expected to Grow Between CAGR of 8.6 During 2019-2025

US breast cancer therapeutics market is estimated to grow significantly at a CAGR of around 9.3% during the forecast period. The factors that enabling the growth of the market includes the prevalence of breast cancer and the initiative by the government and private organization. Breast cancer is the most commonly diagnosed cancer type in the US. According to the American Cancer society it is estimated that about 30% of newly diagnosed cancers in women is breast cancer in 2017. About 266,120 new cases of invasive breast cancer and about 63,960 cases of non-invasive breast cancer estimated in 2018 by the American Cancer Society. About 40,920 women were died in the US by the breast cancer in 2018 that further encourages the demand of treatment solution in therefore contribute in the market.

To Request a Sample of our Report on US Breast Cancer Therapeutics Market: https://www.omrglobal.com/request-sample/us-breast-cancer-therapeutics-market

US breast cancer therapeutics market are segmented on the basis of therapy. The Therapy segment is further classified into chemotherapy, hormone therapy, targeted therapy, radiation therapy and others (surgery). Among all therapies, chemotherapy market held the largest market share in the US breast cancer therapeutics market. Chemotherapy is most used when cancer in the lymph nodes and irrespective of tumor size or menopausal status. Along with that it is used for the treatment of breast cancer in premenopausal women and referred for those women who diagnosed with early stage breast cancer for hormone receptor negative and HER2 positive cancer. The types of chemotherapy include adjuvant chemotherapy and neoadjuvant chemotherapy. The adjuvant chemotherapy is used to destroy cancer cells that have been spread and not seen by the imaging tests. This method helps in reducing the cancer cells that form a new tumor in the other place of the body. Adjuvant chemotherapy reduces the risk of breast cancer coming back. Neoadjuvant chemotherapy can be used to reduce the size of the tumor, so it can be removed with less widespread surgery.

(Get 15% Discount on Buying this Report)

A full Report of US Breast Cancer Therapeutics Market is Available @ https://www.omrglobal.com/industry-reports/us-breast-cancer-therapeutics-market

US Breast Cancer Therapeutics Market Segmentation

By Therapy

· Chemotherapy

· Hormone Therapy

· Targeted Therapy

· Radiation Therapy

· Others (Surgery)

Company Profiles

· AbbVie Inc.

· Amgen Inc.

· Astellas Pharma Inc.

· Bristol-Myers Squibb Co.

· Celldex Therapeutics, Inc.

· Eli Lilly and Co.

· Halozyme, Inc.

· Johnson & Johnson Services Inc.

· Merck & Co., Inc.

· MacroGenics, Inc.

· Pfizer Inc.

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.